Last reviewed · How we verify
Reglan ODT
At a glance
| Generic name | Reglan ODT |
|---|---|
| Sponsor | UCB Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed. (NA)
- A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective. (NA)
- A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reglan ODT CI brief — competitive landscape report
- Reglan ODT updates RSS · CI watch RSS
- UCB Pharma portfolio CI